SEC Comment Letter 0000000000-24-010631 to Starbox Group Holdings Ltd. (STBX) (CIK 0001914818) (STBXF)
Starbox Group Holdings Ltd. (STBX) (CIK 0001914818)
Date: Sept. 19, 2024 · CIK: 0001914818 · Accession: 0000000000-24-010631
AI Filing Summary & Sentiment
File numbers found in text: 333-281748
Show Raw Text
September 19, 2024
Lee Choon Wooi
Chief Executive Officer
Starbox Group Holdings Ltd.
VO2-03-07, Velocity Office 2, Lingkaran SV, Sunway Velocity, 55100
Kuala Lumpur, Malaysia
Re:Starbox Group Holdings Ltd.
Registration Statement on Form F-3
Filed August 23, 2024
File No. 333-281748
Dear Lee Choon Wooi:
We have conducted a limited review of your registration statement and have the following
comment(s).
Please respond to this letter by amending your registration statement and providing the
requested information. If you do not believe a comment applies to your facts and circumstances
or do not believe an amendment is appropriate, please tell us why in your response.
After reviewing any amendment to your registration statement and the information you
provide in response to this letter, we may have additional comments.
Registration Statement on Form F-3
Capitalization and Indebtedness, page 6
1.Please update your capitalization and indebtedness information to a date no earlier than 60
days prior to the date of the F-3. Refer to Item 3(B) of Form 20-F.
Selling Shareholders, page 26
2.To provide additional context to investors, please describe the transactions through which
each of the selling shareholders received their shares. Additionally, please provide the
address for each of the selling shareholders. See Item 9(D) of Form 20-F.
September 19, 2024
Page 2
General
3.We note that you are holding a meeting of shareholders on October 23, 2024 to vote on
proposals for a reverse stock split of your Class A, Class B and preferred stock, followed
by an increase in authorized shares of each class. Revise your disclosure in the
registration statement to discuss the planned reverse stock split and increase in authorized
shares as well as the impact on share capital if the reverse stock split and increase in
authorized shares are approved. Include a risk factor(s) highlighting potential impacts of
the increase in authorized shares on current shareholders such as increased dilution and
downward share pressure. Please also indicate whether you have any plans, proposals or
arrangements for the issuance of shares that will result from the proposed increase in
authorized shares.
4.Please update your disclosure regarding the status of your compliance with Nasdaq’s
continued listing criteria. In this regard, we note that on November 27, 2023 and May 30,
2024, you received written notifications from Nasdaq notifying you that you are not in
compliance with the Minimum Bid Price Rule, and that you have until November 25,
2024 to regain compliance. Include risk factor disclosure to address the impact of a
potential delisting on the company and its shareholders.
5.We note that in July 2023 your shares traded as high as $4.30 per share and as of
September 23, 2023 you had 71,885,000 shares outstanding. It appears that in 2024 alone,
you issued nearly 400 million Class A ordinary shares in connection with 12 separate
transactions, the majority of which were in connection with software purchase
agreements. Currently, your share price is approximately $0.14 per share and there are
approximately 342 million shares outstanding as of August 22, 2024.
Revise throughout to discuss these transactions including the number and frequency of the
transactions, the purpose of the transactions, the total number of shares issued, and
fluctuations in your Class A ordinary share trading price during that period. Please also
include specific risk factor disclosure that discusses the material risks from such
issuances and whether you expect in the future to continue executing transactions in the
same size and frequency. If so, disclose your plans to do so and the continued risk to
investors of the frequent issuances, including the potential substantial dilutive impact and
continued downward pressure on the trading price. Please also indicate whether continued
transactions of this size and frequency could result in your inability to meet Nasdaq's
minimum bid price requirement.
We remind you that the company and its management are responsible for the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action or absence of
action by the staff.
Refer to Rules 460 and 461 regarding requests for acceleration. Please allow adequate
time for us to review any amendment prior to the requested effective date of the registration
statement.
September 19, 2024
Page 3
Please contact Alyssa Wall at 202-551-8106 or Erin Jaskot at 202-551-3442 with any
other questions.
Sincerely,
Division of Corporation Finance
Office of Trade & Services
cc:Ying Li